IP Library Granted Patent US 7,335,779
Granted Patent B2
US 7,335,779 · App. 10/429,875 · Granted Feb 26, 2008

Modulation of pathogenicity

Assignee: Quonova, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,335,779
App. No.
10/429,875
Granted
Feb 26, 2008
Kind
B2
Abstract

The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R 1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R 2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A 1 and A 2 each independently represent an optionally substituted C 1 -C 20 -alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR 4 , CO, CO 2 , CS, SO or SO 2 X is selected from the group consisting of S, O, N, NR 4 , SO or SO 2 .

Claims (18)

1. A composition for inhibiting bacterial quorum sensing, comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof and a carrier,

wherein in Formula (I),

R is H, alkyl, cycloalkyl, aryl or heteroaryl;

R1 and R2 is H;

Y1 is C=O;

Y2 is C=O;

A1 represents an optionally substituted 1,2-diazole ring, and A2 represents an optionally substituted alkyl group;

p is 1;

and n is 1.

2. A composition for inhibiting bacterial quorum sensing, comprising a compound or a pharmaceutically acceptable salt thereof and a carrier is

3. A composition of Formula (I) or a pharmaceutically acceptable salt thereof and a carrier,

wherein in Formula (I),

R is H, alkyl, cycloalkyl, aryl or heteroaryl;

R1 and R2 is H;

Y1 is C=O;

Y2 is C=O;

A1 represents an optionally substituted 1 ,2-diazole ring, and A2 represents an optionally substituted alkyl group; and p=n=1.

4. The composition according to claim 3 , further comprising at least one additional component selected from the group consisting of fillers, extenders, disintegrants, binders, glidants, wetting agents, stabilizers, emulsifiers, preservatives, sweetening agents, colorants, flavorings or aromatizers, buffer substances, solvents, solubilizers, salts for modifying osmotic pressure, coating agents and antioxidants.

Assignments (4)
QUITCLAIM DEED Recorded Jan 7, 2009
From: LV ADMINISTRATIVE SERVICES, INC.
To: QUONOVA, LLC
Reel/Frame 022062/0439 →
AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 8, 2008
From: XL TECHGROUP, INC.; DXTECH, LLC; PETROALGAE, LLC; QUONOVA, LLC
To: LV ADMINISTRATIVE SERVICES, INC.
Reel/Frame 021205/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2007
From: 4 SC AG
To: QUONOVA, LLC
Reel/Frame 019581/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2003
From: AMMENDOLA, ALDO; AULINGER-FUCHS, KATHARINA; GOTSCHLICH, ASTRID; KRAMER, BERND; LANG, MARTIN; SAEB, WAEL; SINKS, UDO; WUZIK, ANDREAS
To: 4 SC AG
Reel/Frame 014704/0387 →
Continuity (2)
Continuation In Part 1009430100 · Mar 8, 2002
Related Publication 20040063765A1 · Apr 1, 2004